公开(公告)号：US20190099366A1

公开(公告)日：2019-04-04

申请号：US16094506

申请日：2017-04-19

申请人： PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY

发明人： Tsutomu Yasukawa

IPC分类号： A61K9/00 ,  A61F9/007 ,  A61M31/00

摘要： An object of the present invention is to provide a sustained drug release system useful for treating eye diseases. There is provided a device for sustained release of an ophthalmic drug, comprising a drug enclosing part and an intraocular retention gas enclosing part adjacent to the drug enclosing part, the enclosing parts being provided in a hollow container having at least one opening part, wherein the drug enclosing part is isolated from the opening part by the intervention of the intraocular retention gas enclosing part.

公开(公告)号：US11219598B2

公开(公告)日：2022-01-11

申请号：US16094506

申请日：2017-04-19

申请人： PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY

发明人： Tsutomu Yasukawa

IPC分类号： A61K9/00 ,  A61F9/007 ,  A61M31/00

摘要： An object of the present invention is to provide a sustained drug release system useful for treating eye diseases. There is provided a device for sustained release of an ophthalmic drug, comprising a drug enclosing part and an intraocular retention gas enclosing part adjacent to the drug enclosing part, the enclosing parts being provided in a hollow container having at least one opening part, wherein the drug enclosing part is isolated from the opening part by the intervention of the intraocular retention gas enclosing part.